title: Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications.
authors.affiliation: Winnipeg Regional Health Authority, Manitoba Renal Program, Winnipeg, MB. craymond@exchange.hsc.mb.ca
authors.forename: Colette B
authors.initials: CB
authors.lastname: Raymond
authors.forename: Lance
authors.initials: L
authors.lastname: Breland
authors.forename: Lori D
authors.initials: LD
authors.lastname: Wazny
authors.forename: Amy R
authors.initials: AR
authors.lastname: Sood
authors.forename: Cali D
authors.initials: CD
authors.lastname: Orsulak
mesh_terms: D015259:Dopamine Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000451:nursing; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D012307:Risk Factors
chemical_list: D015259:Dopamine Agents; D007980:Levodopa